Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.87 | -30.1038062284 | 2.89 | 3.09 | 1.85 | 1152953 | 2.43893487 | CS |
4 | -5.18 | -71.9444444444 | 7.2 | 8.98 | 1.85 | 707924 | 3.55272997 | CS |
12 | -3.2 | -61.3026819923 | 5.22 | 11.41 | 1.85 | 427427 | 4.55055248 | CS |
26 | -2.27 | -52.9137529138 | 4.29 | 11.41 | 1.85 | 531387 | 5.2769767 | CS |
52 | -10.03 | -83.2365145228 | 12.05 | 13.64 | 1.77 | 317838 | 5.19850591 | CS |
156 | -12.11 | -85.7041755131 | 14.13 | 18.67 | 1.77 | 229507 | 6.24512198 | CS |
260 | 0 | 0 | 0 | 2.14 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관